The FDA and the Federal Communications Commission are collaborating as well as separately pursuing efforts to advance the development of wireless and innovative medical devices. The FCC is close to completing regulations that will make it easier to test wireless technologies, said Kerry McDermott, the agency's director of health care. Meanwhile, the FDA is reviewing a pilot application for a neuroprosthetic arm as part of its innovation pathway program that aims to accelerate device approvals.

Related Summaries